AC

Aparna Chakraborty

Active Director Director DIN 06927690
DIN 06927690 First appointment Jul 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2014
Shareholding value •••• Premium profile

About Aparna Chakraborty

Data last updated:

Aparna Chakraborty is a Director at Koronis Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Koronis Pharmaceutical Private Limited reported revenue of ₹1.93 Cr (FY 2023).

DIN 06927690
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2014
Oldest Company Age 15 yrs
Largest company Koronis Pharmaceutical Private Limited · ₹1.93 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Jul 20142011₹1.93 Cr (FY 2023)Active

Board colleagues of Aparna Chakraborty

Directorship timeline

Open interactive timeline →
Koronis Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Aparna Chakraborty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aparna Chakraborty

Aparna Chakraborty currently holds 1 directorship: Koronis Pharmaceutical Private Limited (Director, since 17 Jul 2014, revenue ₹1.93 Cr (FY 2023)).

Aparna Chakraborty was first appointed on 17 Jul 2014 as Director at Koronis Pharmaceutical Private Limited.

The current boards of Aparna Chakraborty's companies include Geetopriyo Chokroborty (Koronis Pharmaceutical Private Limited), Gobinda K Chakravarty (Koronis Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available